Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon Duk Hong

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Research in Social & Administrative Pharmacy : RSAP|December 18, 2018
Medication errors in community pharmacies: The need for commitment, transparency, and researchKyungwan Hong, Yoon Duk Hong, Catherine E Cooke
Journal of Managed Care & Specialty Pharmacy|September 30, 2020
The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary DiseaseYoon Duk Hong, Eberechukwu Onukwugha, Julia F Slejko
Journal of Comparative Effectiveness Research|May 10, 2017
Querying stakeholders to inform comparative effectiveness researchYoon Duk Hong, Daisuke Goto, C Daniel Mullins
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug AdministrationYoon Duk Hong, Ester Villalonga-Olives, Eleanor M Perfetto
Journal of the National Cancer Institute|October 25, 2024
Assessing the effect of the COVID-19 pandemic on 1-year cancer survival in the United StatesYoon Duk Hong, Nadia Howlader, Anne-Michelle Noone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2024
Assessing 1-Year Comorbidity Prevalence and Its Survival Implications in Medicare Beneficiaries Diagnosed with Cancer: Insights from a New SEER-Medicare ResourceAnne-Michelle Noone, Angela B Mariotto, Yoon Duk Hong, et al.
Qualitative Health Research|March 23, 2021
Are Communities Willing to Transition Into Learning Health Care Communities? A Community-Based Participatory Evaluation of Stakeholders' ReceptivityNabil Natafgi, Olayinka Ladeji, Yoon Duk Hong, et al.
Pharmacoepidemiology and Drug Safety|December 29, 2023
Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor-agnostic indicationYoon Duk Hong, Lindsey Enewold, Michael T Halpern, et al.
The Patient|February 22, 2021
Correction to: Prioritization and Refinement of Patient-Informed Value Elements as Attributes for Chronic Obstructive Pulmonary Disease Treatment PreferencesJulia F Slejko, Yoon Duk Hong, Jamie L Sullivan, et al.
The Patient|February 8, 2021
Prioritization and Refinement of Patient-Informed Value Elements as Attributes for Chronic Obstructive Pulmonary Disease Treatment PreferencesJulia F Slejko, Yoon Duk Hong, Jamie L Sullivan, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Research in Social & Administrative Pharmacy : RSAP|December 18, 2018
Medication errors in community pharmacies: The need for commitment, transparency, and researchKyungwan Hong, Yoon Duk Hong, Catherine E Cooke
Journal of Managed Care & Specialty Pharmacy|September 30, 2020
The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary DiseaseYoon Duk Hong, Eberechukwu Onukwugha, Julia F Slejko
Journal of Comparative Effectiveness Research|May 10, 2017
Querying stakeholders to inform comparative effectiveness researchYoon Duk Hong, Daisuke Goto, C Daniel Mullins
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug AdministrationYoon Duk Hong, Ester Villalonga-Olives, Eleanor M Perfetto
Journal of the National Cancer Institute|October 25, 2024
Assessing the effect of the COVID-19 pandemic on 1-year cancer survival in the United StatesYoon Duk Hong, Nadia Howlader, Anne-Michelle Noone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2024
Assessing 1-Year Comorbidity Prevalence and Its Survival Implications in Medicare Beneficiaries Diagnosed with Cancer: Insights from a New SEER-Medicare ResourceAnne-Michelle Noone, Angela B Mariotto, Yoon Duk Hong, et al.
Qualitative Health Research|March 23, 2021
Are Communities Willing to Transition Into Learning Health Care Communities? A Community-Based Participatory Evaluation of Stakeholders' ReceptivityNabil Natafgi, Olayinka Ladeji, Yoon Duk Hong, et al.
Pharmacoepidemiology and Drug Safety|December 29, 2023
Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor-agnostic indicationYoon Duk Hong, Lindsey Enewold, Michael T Halpern, et al.
The Patient|February 22, 2021
Correction to: Prioritization and Refinement of Patient-Informed Value Elements as Attributes for Chronic Obstructive Pulmonary Disease Treatment PreferencesJulia F Slejko, Yoon Duk Hong, Jamie L Sullivan, et al.
The Patient|February 8, 2021
Prioritization and Refinement of Patient-Informed Value Elements as Attributes for Chronic Obstructive Pulmonary Disease Treatment PreferencesJulia F Slejko, Yoon Duk Hong, Jamie L Sullivan, et al.
Pageof 2